Form 4: Verizon Executive Kyle Malady Reports Acquisition of Phantom Stock

Sentiment:

SEC Form 4 Filing


EVP and Group CEO of Verizon Business, Kyle Malady, reports acquiring phantom stock units equivalent to 142.206 shares of common stock through a deferred compensation plan.

Summary

  • On October 10, 2024, Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., reported acquiring 142.206 units of phantom stock.
  • These phantom stock units are the economic equivalent of common stock shares and will be settled in cash upon certain events as per the deferred compensation plan.
  • Following the reported transaction, Malady's beneficial ownership includes 353,378.052 shares of common stock, including phantom stock acquired through dividend reinvestment, held indirectly through a deferred compensation plan.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like executives and directors, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders.
  • It provides transparency to shareholders regarding executive compensation and stock ownership.

Key Dates

DateDescription
10/10/2024Date of transaction: Kyle Malady acquired phantom stock.
10/15/2024Date of report filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.